即刻乳房重建后辅助化疗延迟的风险因素
该回顾性研究纳入2010至2015年单中心182例(244侧)即刻乳房重建后接受辅助化疗患者,分析术后并发症对化疗时机的影响。发生并发症者化疗启动延迟(56天 vs 45天,p=0.017),年龄>51.7岁、糖尿病和自体重建为延迟风险因素,具备至少一项者化疗延迟概率74%。
要点
- 术后并发症组化疗启动时间较无并发症组延迟(56天 vs 45天,p=0.017)。
- 延迟化疗风险因素为年龄>51.7岁、糖尿病和自体重建。
- 具备至少一项风险因素者化疗延迟概率为74%。
核心结论
- 术后并发症背景下化疗延迟的风险因素为年龄大于51.7岁、糖尿病和自体重建。
- 符合上述特征的重建候选者风险最高,值得额外考虑。
研究设计与样本
- 回顾性病历审查,纳入2010至2015年单中心接受即刻乳房重建和辅助化疗的患者。
- 共纳入182例患者(244侧乳房重建),按术后并发症发生情况和化疗时间进行分析。
主要发现
- 210侧(86%)重建未发生术后并发症,34侧(13.9%)发生并发症。
- 发生并发症组平均年龄更大(53.6岁 vs 48.1岁,p=0.002),糖尿病比例更高(23.5% vs 3.8%,p<0.001)。
- 并发症组化疗启动延迟(56天 vs 45天,p=0.017)。
- 重建后超过48.5天启动化疗者平均年龄更大(55.9岁 vs 50.7岁,p=0.074),糖尿病比例更高(36.8% vs 6.7%,p=0.053),即刻自体重建比例更高(31.6% vs 0%,p=0.027)。
- 预测模型显示具备至少一项风险因素者化疗延迟概率为74%。
关键数值与推荐
- 化疗延迟的风险因素为年龄大于51.7岁、糖尿病和自体重建。
- 具备至少一项风险因素者化疗延迟概率为74%。
临床怎么用
- 作者认为符合年龄大于51.7岁、糖尿病或自体重建特征的重建候选者风险最高,值得额外考虑。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Concerns exist that immediate breast reconstruction may delay adjuvant chemotherapy initiation, impacting oncologic outcomes. Here, the authors determine how postoperative complications impact chemotherapy timing, and identify factors associated with greater risk for delays. METHODS: Retrospective chart review identified patients undergoing immediate breast reconstruction and adjuvant chemotherapy at a single institution from 2010 to 2015. Patients were analyzed based on occurrence of postoperative complications and time to chemotherapy. RESULTS: A total of 182 patients (244 breast reconstructions) were included in the study; 210 (86 percent) reconstructions did not experience postoperative complications, and 34 (13.9 percent) did. Patients who experienced postoperative complications had an older mean age (53.6 years versus 48.1 years; p = 0.002) and higher rates of diabetes (23.5 percent versus 3.8 percent; p < 0.001). The complication group had delays in initiation of chemotherapy (56 versus 45 days; p = 0.017). Patients who initiated chemotherapy more than 48.5 days after reconstruction were of older mean age (55.9 years versus 50.7 years; p = 0.074) and had increased rates of diabetes (36.8 percent versus 6.7 percent; p = 0.053) and immediate autologous reconstruction (31.6 percent versus 0 percent; p = 0.027). A predictive model determined that patients with at least one of these three risk factors have a 74 percent chance of experiencing prolonged times to chemotherapy initiation. CONCLUSIONS: Risk factors for delayed chemotherapy in the context of postoperative complications are age older than 51.7 years, diabetes, and autologous reconstruction. Reconstructive candidates who fit this profile are at highest risk and merit extra consideration. CLINICAL QUESTION/LEVEL OF EVIDENCE: Risk, III.
引用
- Cohen O, Lam G, Choi M, et al. Risk Factors for Delays in Adjuvant Chemotherapy following Immediate Breast Reconstruction. Plast Reconstr Surg. 2018. PMID: 29782396. doi:10.1097/PRS.0000000000004547
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。